In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Metlife Inc (NYSE: MET) closed at $78.32 down -1.37% from its previous closing price of $79.41. In other words, the price has decreased by -$1.37 from its previous closing price. On the day, 3.61 million shares were traded. MET stock price reached its highest trading level at $79.1 during the session, while it also had its lowest trading level at $78.0175.
Ratios:
For a deeper understanding of Metlife Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.69.
On December 16, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $101.
Piper Sandler Downgraded its Overweight to Neutral on September 19, 2025, while the target price for the stock was maintained at $84.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 09 ’26 when MetLife Separate Account SPI bought 562 shares for $79.78 per share.
Russell 1000 Value MetLife 401 bought 68 shares of MET for $5,556 on Dec 19 ’25. On Dec 19 ’25, another insider, Metlife 401(k) Plan Large cap, who serves as the Affiliate discretionary manage of the company, bought 359 shares for $81.71 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MET now has a Market Capitalization of 52084838400 and an Enterprise Value of 70544392192. As of this moment, Metlife’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.75, and their Forward P/E ratio for the next fiscal year is 7.95. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.75. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.72 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 0.981 whereas that against EBITDA is 12.415.
Stock Price History:
The Beta on a monthly basis for MET is 0.76, which has changed by -0.052725732 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, MET has reached a high of $88.09, while it has fallen to a 52-week low of $65.21. The 50-Day Moving Average of the stock is -0.59%, while the 200-Day Moving Average is calculated to be -0.15%.
Shares Statistics:
For the past three months, MET has traded an average of 3.43M shares per day and 2829420 over the past ten days. A total of 660.72M shares are outstanding, with a floating share count of 549.02M. Insiders hold about 16.67% of the company’s shares, while institutions hold 78.89% stake in the company. Shares short for MET as of 1767139200 were 8553459 with a Short Ratio of 2.49, compared to 1764288000 on 9306296. Therefore, it implies a Short% of Shares Outstanding of 8553459 and a Short% of Float of 1.5599999999999998.
Dividends & Splits
According to the company, the forward annual dividend rate for MET is 2.25, from 2.225 in the trailing year. Against a Trailing Annual Dividend Yield of 0.02801914. The stock’s 5-year Average Dividend Yield is 2.96. The current Payout Ratio is 36.26% for MET, which recently paid a dividend on 2025-11-04 with an ex-dividend date of 2026-02-03. Stock splits for the company last occurred on 2017-08-07 when the company split stock in a 1122:1000 ratio.
Earnings Estimates
The firm’s stock currently is rated by 15.0 analysts. The consensus estimate for the next quarter is $2.21, with high estimates of $2.38 and low estimates of $2.06. Analysts are recommending an EPS of between $8.8 and $8.58 for the fiscal current year, implying an average EPS of $8.71. EPS for the following year is $9.87, with 15.0 analysts recommending between $10.2 and $9.45.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $31.33B this quarter.It ranges from a high estimate of $33.72B to a low estimate of $30.05B. As of. The current estimate, Metlife Inc’s year-ago sales were $19.74BFor the next quarter, 5 analysts are estimating revenue of $19.02B. There is a high estimate of $19.75B for the next quarter, whereas the lowest estimate is $18.44B.
A total of 6 analysts have provided revenue estimates for MET’s current fiscal year. The highest revenue estimate was $88.37B, while the lowest revenue estimate was $83.22B, resulting in an average revenue estimate of $85.48B. In the same quarter a year ago, actual revenue was $73.05BBased on 9 analysts’ estimates, the company’s revenue will be $78.09B in the next fiscal year. The high estimate is $81.51B and the low estimate is $74.66B.
